Table 1 Characteristics of participants
Characteristics | Healthy (n = 145) | IDA (n = 59) | Non-IDA ESRD (n = 50) | IDA ESRD (n = 58) |
|---|---|---|---|---|
Age (years) | ||||
Mean ± SD | 36 ± 10.8 | 39.7 ± 10.8 | 50.3 ± 15.9 | 53.7 ± 16.8 |
< 30 | 46 (31.7) | 13 (22.0) | 5 (10.0) | 3 (5.2) |
30–40 | 61 (42.1) | 16 (27.1) | 11 (22.0) | 12 (20.7) |
41–50 | 22 (15.2) | 23 (39.0) | 6 (12.0) | 9 (15.5) |
51–60 | 11 (7.6) | 5 (8.5) | 11 (22.0) | 20 (34.5) |
> 60 | 5 (3.4) | 2 (3.4) | 17 (34.0) | 14 (24.1) |
Gender, n (%) | ||||
Male | 72 (49.7) | 14 (23.7) | 17 (34.0) | 21 (36.2) |
Female | 73 (50.3) | 45 (76.3) | 33 (66.0) | 37 (63.8) |
Hb (g/l) | ||||
Mean ± SD | 144.5 ± 12.3 | 90.4 ± 18.4 | 96.2 ± 18.1 | 92.7 ± 17.5 |
CHr | ||||
Mean ± SD | 31.2 ± 1.2 | 23.4 ± 3.2 | 31.5 ± 1.9 | 29.3 ± 2.8 |
%Hypo | ||||
Median (IQR) | 2.1 (1.3–3.6) | 30.9 (14.0–54.0) | 4.2 (1.4–7.6) | 9.2 (4.4–18.3) |
MCHC | ||||
Mean ± SD | 330.2 ± 8.2 | 302.7 ± 23.7 | 322.3 ± 10.8 | 315.8 ± 13.6 |
MCV | ||||
Mean ± SD | 91.3 ± 4.1 | 70.6 ± 9.9 | 92.3 ± 4.8 | 88 ± 8.8 |
Ferritin (ng/ml) | ||||
Median (IQR) | 6.0 (4.2–9.5) | 547.5 (358.1–891.5) | 339.5 (108.3–744.6) | |
TSAT (%) | ||||
Median (IQR) | 30.0 (25.7–36.5) | 11.0 (6.7–16.1) | ||
Transferrin (ng/ml) | ||||
Median (IQR) | 174.9 (151.3–199.3) | 170.0 (144.1–195.3) | ||